search
Back to results

Laparoscopically Guided Rectus Sheath Block in Pediatric Appendicitis

Primary Purpose

Appendicitis Acute

Status
Recruiting
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Rectus Sheath Block with 0.25% bupivicaine with 1:200 000 epinephrine
Local Anesthetic Infiltration with 0.25% bupivicaine with 1:200 000 epinephrine
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Appendicitis Acute

Eligibility Criteria

8 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of acute uncomplicated appendicitis
  • Age 8-17 years

Exclusion Criteria:

  • Complicated appendicitis, perforation, abscess
  • History of chronic pain condition or long-term analgesic use
  • History of bleeding condition
  • Condition preventing accurate documentation of post-operative pain scores using the FPS-R tool including severe developmental delay, psychiatric illness, or partially sighted or blindness
  • Previous open abdominal surgery
  • Presence of an abdominal prosthesis such as a gastrostomy tube or ventricular-peritoneal shunt device
  • Allergy to bupivacaine or morphine

Sites / Locations

  • Stollery Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Rectus Sheath Block

Local Anesthetic

Arm Description

Participants randomized to the experimental arm will receive a bilateral rectus sheath block which is additional to the standard of care (infiltration of 5mg (2mL) 0.25% bupivacaine with epinephrine around port site incisions). For rectus sheath block, use the formula Volume (ml) = 2mg/kg x weight (kg) divided by 2.5mg/ml - 6ml to a maximum of 14ml. Maximum total dose is 2mg/kg. Participants will be asked to rate their pain a total of 4 times for the study. Each occurrence is expected to take approximately 1-2 minutes to complete. There will be no additional follow-up required as part of the study. The 6 week follow-up visit is standard routine practice.

Participants in the control arm will receive the standard care which is infiltration of 5mg (2mL) of 0.25% bupivacaine with epinephrine around port site incisions. Participants will be asked to rate their pain a total of 4 times for the study. Each occurrence is expected to take approximately 1-2 minutes to complete. There will be no additional follow-up required as part of the study. The 6 week follow-up visit is standard routine practice.

Outcomes

Primary Outcome Measures

Self-reported pain scores at 3 hours post-operatively
Reported with Faces Pain Scale - Revised. Scale runs from 0-10 with 0 being no pain and 10 being the worst pain they have experienced.

Secondary Outcome Measures

Self-reported pain scores in recovery room, at 6 hours post-operatively, and prior to discharge home
Reported with Faces Pain Scale - Revised. Scale runs from 0-10 with 0 being no pain and 10 being the worst pain they have experienced.
Intra-operative narcotic use in mg/kg morphine equivalents
Opioid medications administered intra-operatively
Post-operative narcotic use in mg/kg morphine equivalents
Opioid medications administered post-operatively
Post-operative anti-emetic use mg/kg or ondansetron and dimenhydrinate
Anti-emetic medications (ondansetron and dimenhydrinate) administered post-operatively

Full Information

First Posted
January 13, 2021
Last Updated
March 7, 2023
Sponsor
University of Alberta
search

1. Study Identification

Unique Protocol Identification Number
NCT04717193
Brief Title
Laparoscopically Guided Rectus Sheath Block in Pediatric Appendicitis
Official Title
Laparoscopically Guided Rectus Sheath Block in Pediatric Appendicitis - a Randomized Control Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 28, 2021 (Actual)
Primary Completion Date
January 2024 (Anticipated)
Study Completion Date
April 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Alberta

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The study will investigate the pain control effects of a rectus sheath block after laparoscopic surgery to remove the appendix. A rectus sheath block is the injection of local anesthetic (numbing agent) into the space between the muscles of the belly wall. Children having surgery for appendicitis age 8-17 at the Stollery Children's Hospital will be eligible to participate. Patients with complicated appendicitis (perforation or abscess), chronic pain, bleeding disorders, or inability to document pain scores will be excluded from this study. Participants will be randomly assigned to either rectus sheath block or standard local anesthetic. The standard local anesthetic group will have local anesthetic (numbing agent) injected around their surgery cut sites. The rectus sheath block group will have this standard plus the rectus sheath block with local anesthetic. Participants, parents, anesthesiologists and nursing staff will not know which group the participant has been assigned to. The surgeon will know the group. The same pain and nausea medications will be ordered for all participants after the surgery. Pain scores will be measured using the Faces Pain Scale - Revised tool. Participants will be asked to rate their pain in the recovery room, in their hospital room at 3 and 6 hours after the surgery and again before going home. This tool has been shown to be useful for rating children's pain levels. The study will also measure the amount of pain and nausea medications that participants are given during their surgery and recovery. Participants will see their surgeon at 6 weeks after their surgery where they will be asked about any problems after being discharged home. Data will be analyzed with a linear mixed model.
Detailed Description
Purpose: To determine if a bilateral laparoscopically guided rectus sheath block improves pain control over conventional local anesthetic infiltration around port site incisions following laparoscopic appendectomy. Hypothesis: Bilateral rectus sheath block will improve post-operative pain scores following laparoscopic appendectomy for acute uncomplicated appendicitis. Justification: Children have significant pain after laparoscopic appendectomy and many receive post-operative opioids for analgesia. The Faces pain scale - revised (FPS-R) is a simple validated method of measuring post-operative pain in children. Ultrasound-guided bilateral rectus sheath block (RSB) has been shown to decrease pain scores in the early post-operative period following pediatric laparoscopic appendectomy and elective umbilical hernia repair.2,4 The use of image-guidance for needle placement has improved both achievement of appropriate anatomic location of the block as well as analgesia associated with the block. Under ultrasound guidance, this extra step requires additional equipment, time, and sometimes dedicated personnel to complete. The investigators propose a bilateral RSB performed intra-operatively under laparoscopic guidance may alleviate the need for these extra resources while achieving the desired analgesic effects. The analgesic effect of the standard of care injection of local anesthesia is limited to the superficial layers of the abdominal wall. The rectus sheath block targets the nerves running within the fascia and provides a more complete block to the deep and superficial layers of the abdominal wall. Objectives: Primary Objective: Determine if intra-operative laparoscopic guided bilateral RSB improves self-reported post-operative pain scores at 3 hours post-operatively. Secondary Objectives: Determine if intra-operative laparoscopic guided bilateral RSB improves self-reported post-operative pain scores in the PACU, at 6 hours post-operatively, and prior to discharge home. Determine if intra-operative bilateral laparoscopic guided bilateral RSB decreases intra-operative narcotic use, post-operative opioid use, and post-operative antiemetic use. Research Methods/Procedures: Randomization: Simple Blinding: Single-blind. Surgeon cannot be blinded to the intervention. Anesthesiologist, participants, parents, and nursing staff in the OR, recovery room, and ward will be blinded. Control: Standard of care infiltration of local anesthetic at incisions. Treatment and standard care arms will run in parallel. Standard Care: Intra-operative infiltration of 2ml of 0.25% Bupivacaine with 1:200 000 epinephrine at each port site incision. Experimental Treatment: Bilateral RSB with up to 7ml of 0.25% Bupivacaine with 1:200 000 epinephrine plus 2ml infiltrated around each port site incision as in the standard care group. The total volume used will not exceed 20ml or 2mg/kg, whichever is lower. Each participant will be followed in the recovery room and surgical ward and asked to report their pain level immediately after surgery, at 3 and 6 hours after surgery, and prior to discharge home. Each participant will have a scheduled follow up visit at 6 weeks with their operating surgeon where they will be asked about any complications experienced since discharge. Participation will be voluntary. Participants will receive standard of care if they choose not to participate in the study. Informed consent will be obtained from the participant's parent or legal guardian by the operating surgeon or delegate pre-operatively. Participants will be asked to provide assent. Plan for Data Analysis: 100 participants will be required with a target of 50 in each group. Sample size calculations were completed based on an estimated 20% effect size with consideration for a potential 10-15% dropout rate to achieve a power of 80% and alpha 5%. Effect size is estimated conservatively from data in previous studies showing an average 30% decrease in early post-operative pain scores. Data will be analyzed in an intent to treat manner using a linear mixed model. We have undertaken an initial consultation with a WCHRI biostatistician.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Appendicitis Acute

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Single-blind. Surgeon cannot be blinded to the intervention. Anesthesiologist, participants, parents, and nursing staff in the OR, recovery room, and ward will be blinded.
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Rectus Sheath Block
Arm Type
Experimental
Arm Description
Participants randomized to the experimental arm will receive a bilateral rectus sheath block which is additional to the standard of care (infiltration of 5mg (2mL) 0.25% bupivacaine with epinephrine around port site incisions). For rectus sheath block, use the formula Volume (ml) = 2mg/kg x weight (kg) divided by 2.5mg/ml - 6ml to a maximum of 14ml. Maximum total dose is 2mg/kg. Participants will be asked to rate their pain a total of 4 times for the study. Each occurrence is expected to take approximately 1-2 minutes to complete. There will be no additional follow-up required as part of the study. The 6 week follow-up visit is standard routine practice.
Arm Title
Local Anesthetic
Arm Type
Active Comparator
Arm Description
Participants in the control arm will receive the standard care which is infiltration of 5mg (2mL) of 0.25% bupivacaine with epinephrine around port site incisions. Participants will be asked to rate their pain a total of 4 times for the study. Each occurrence is expected to take approximately 1-2 minutes to complete. There will be no additional follow-up required as part of the study. The 6 week follow-up visit is standard routine practice.
Intervention Type
Drug
Intervention Name(s)
Rectus Sheath Block with 0.25% bupivicaine with 1:200 000 epinephrine
Intervention Description
Bilateral rectus sheath block plus infiltration local anesthetic at incision sites.
Intervention Type
Procedure
Intervention Name(s)
Local Anesthetic Infiltration with 0.25% bupivicaine with 1:200 000 epinephrine
Intervention Description
Infiltration of local anesthetic at incision sites.
Primary Outcome Measure Information:
Title
Self-reported pain scores at 3 hours post-operatively
Description
Reported with Faces Pain Scale - Revised. Scale runs from 0-10 with 0 being no pain and 10 being the worst pain they have experienced.
Time Frame
3 hours
Secondary Outcome Measure Information:
Title
Self-reported pain scores in recovery room, at 6 hours post-operatively, and prior to discharge home
Description
Reported with Faces Pain Scale - Revised. Scale runs from 0-10 with 0 being no pain and 10 being the worst pain they have experienced.
Time Frame
Immediately post-operatively to approximately 24 hours
Title
Intra-operative narcotic use in mg/kg morphine equivalents
Description
Opioid medications administered intra-operatively
Time Frame
Intra-operative
Title
Post-operative narcotic use in mg/kg morphine equivalents
Description
Opioid medications administered post-operatively
Time Frame
Approximately 24 hours
Title
Post-operative anti-emetic use mg/kg or ondansetron and dimenhydrinate
Description
Anti-emetic medications (ondansetron and dimenhydrinate) administered post-operatively
Time Frame
Approximately 24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of acute uncomplicated appendicitis Age 8-17 years Exclusion Criteria: Complicated appendicitis, perforation, abscess History of chronic pain condition or long-term analgesic use History of bleeding condition Condition preventing accurate documentation of post-operative pain scores using the FPS-R tool including severe developmental delay, psychiatric illness, or partially sighted or blindness Previous open abdominal surgery Presence of an abdominal prosthesis such as a gastrostomy tube or ventricular-peritoneal shunt device Allergy to bupivacaine or morphine
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Troy Perry, MD
Phone
7804071537
Email
teperry@ualberta.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Troy Perry, MD
Organizational Affiliation
University of Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
Stollery Children's Hospital
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G2B7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Troy Perry, MD
Phone
7804071537
Email
teperry@ualberta.ca
First Name & Middle Initial & Last Name & Degree
Troy Perry, MD

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Individual participant data will not be made available to other researchers. For inquiries relating to the study protocol or other supporting information, researchers are invited to contact the study's principal investigator.
Citations:
PubMed Identifier
23760519
Citation
Dingeman RS, Barus LM, Chung HK, Clendenin DJ, Lee CS, Tracy S, Johnson VM, Dennett KV, Zurakowski D, Chen C. Ultrasonography-guided bilateral rectus sheath block vs local anesthetic infiltration after pediatric umbilical hernia repair: a prospective randomized clinical trial. JAMA Surg. 2013 Aug;148(8):707-13. doi: 10.1001/jamasurg.2013.1442.
Results Reference
background
PubMed Identifier
21958060
Citation
Tomecka MJ, Bortsov AV, Miller NR, Solano N, Narron J, McNaull PP, Ricketts KJ, Lupa CM, McLean SA. Substantial postoperative pain is common among children undergoing laparoscopic appendectomy. Paediatr Anaesth. 2012 Feb;22(2):130-5. doi: 10.1111/j.1460-9592.2011.03711.x. Epub 2011 Sep 29.
Results Reference
result
PubMed Identifier
25581711
Citation
Hamill JK, Liley A, Hill AG. Rectus sheath block for laparoscopic appendicectomy: a randomized clinical trial. ANZ J Surg. 2015 Dec;85(12):951-6. doi: 10.1111/ans.12950. Epub 2015 Jan 12.
Results Reference
result
PubMed Identifier
11427329
Citation
Hicks CL, von Baeyer CL, Spafford PA, van Korlaar I, Goodenough B. The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement. Pain. 2001 Aug;93(2):173-183. doi: 10.1016/S0304-3959(01)00314-1.
Results Reference
result

Learn more about this trial

Laparoscopically Guided Rectus Sheath Block in Pediatric Appendicitis

We'll reach out to this number within 24 hrs